Bioengineer.org reports that subcutaneous infliximab could reduce treatment costs for autoimmune diseases in Jordan.

First reported

2026-10-29 21:37 (6 d ago)

Last update

2026-10-29 21:37 (6 d ago)

sources

1 sources · 1 Reports

Timeline

1. Google News – Jordan (EN) wire 21:37 · 6 d ago
   Bioengineer.org reports that subcutaneous infliximab could reduce treatment costs for autoimmune diseases in Jordan.
   Read at source ↗

Every event is assembled automatically from the sources listed. Summaries are machine-written in neutral language; the original reports are linked for verification.